Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients

Clinical Transplantation

Volumn 24, Issue 6, 2010, Pages 758-765

  Shi, Shao Hua ^a   Kong, Hai Shen ^a   Jia, Chang Ku ^a   Zhang, Wen Jin ^a   Xu, Jian ^a   Wang, Wei Lin ^a   Shen, Yan ^a   Zhang, Min ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Gram negative bacillus; Liver transplantation; Multidrug resistance; Pneumonia; Risk factors

Indexed keywords

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; BRAIN DISEASE; ENDOTRACHEAL INTUBATION; ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REOPERATION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; TRACHEOSTOMY;

ADULT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LIVER TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 78649809539     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01184.x     Document Type: Article

References (31)

1. Singh N, Chang FY, Gayowski T, Wagener M, Marino IR. Fever in liver transplant recipients in the intensive care unit. Clin Transplant 1999: 13: 504.
2. Saner FH, Olde Damink SWM, Pavlakovic G et al. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients. Transplantation 2008: 85: 1564.
3. Singh N, Gayowski T, Wagener M, Marino IR, Yu VL. Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies. Transplantation 1996: 61: 396.
4. Kwa ALH, Low JG, Lee E, Kurup A, Chee HL, Tam VH. The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia. Diagn Microbiol Infect Dis 2007: 58: 99.
5. Diaz E, Muñoz E, Agbaht K, Rello J. Management of ventilator-associated pneumonia caused by multiresistant bacteria. Curr Opin Crit Care 2007: 13: 45.
6. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing: 12th Informational Supplement. M100-S12. Wayne: NCCLS, 2002.
7. Shi SH, Lu AW, Shen Y et al. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chin Med J 2008: 121: 625.
8. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definition and causes. Semin Liver Dis 1986: 6: 97.
9. Beck KD, Gastmerier P. Clinical or epidemiologic diagnosis of nosocomial pneumonia: is there any difference? Am J Infect Control 2003: 31: 331.
10. Pelletier SJ, Crabtree TD, Gleason TG et al. Characteristics of infectious complications associated with mortality after solid organ transplantation. Clin Transplant 2000: 14: 401.
11. Saiman L, Mehar F, Niu WW et al. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 1996: 23: 532.
12. Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 2007: 109: 2615.
13. Muder RR, Brennen C, Drenning SD, Stout JE, Wagener MM. Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol 1997: 18: 809.
14. Husni RN, Goldstein LS, Arroliga AC et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999: 115: 1378.
15. Ferrara AM. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents 2006: 27: 183.
16. Park DR. The microbiology of ventilator-associated pneumonia. Respir Care 2005: 50: 742.
17. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996: 153: 1711.
18. Emmerson M. Antibiotic usage and prescribing policies in the intensive care unit. Intensive Care Med 2000: 26(Suppl. 1): S26.
19. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997: 76: 30.
20. Liu CE, Wong WW, Yang SP et al. Flavobacterium meningosepticum bacteremia: an analysis of 16 cases. Zhonghua Yi Xue Za Zhi (Taipei) 1999: 62: 125.
21. Gales AC, Jones RN, Forward KR, Liñares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001: 32(Suppl. 2): S104.
22. Hong SK, Hwang S, Lee SG et al. Pulmonary complications following adult liver transplantation. Transplant Proc 2006: 38: 2979.
23. Pomposelli JJ, Jenkins RL. Liver transplantation in patients with fulminant and sub-fulminant hepatitis. In: Blumgart LH, Fong Y eds. Surgery of the Liver and Biliary Tract, Vol. 2, 3rd edn. Health Science Asia: Elsevier Science, 2002: 2087.
24. Towner KJ. Clinical importance and antibiotic resistance of Acinetobacter spp. Proceedings of a symposium held on 4-5 November 1996 at Eilat, Israel. J Med Microbiol 1997: 46: 721.
25. Karlowsky JA, Jones ME, Thornsberry C, Evangelista AT, Yee YC, Sahm DF. Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. Clin Infect Dis 2005: 40(Suppl. 2): S89.
26. Ferrer R, Artigas A. Clinical review: non-antibiotic strategies for preventing ventilator-associated pneumonia. Crit Care 2002: 6: 45.
27. Palma F, Jimenez C, Moreno E et al. Recipient factors as determinants of mortality after adult liver transplantation. World J Surg 1999: 23: 1282.
28. Kuo LC, Lai CC, Liao CH et al. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome. Clin Microbiol Infect 2007: 13: 196.
29. Lortholary O, Fagon JY, Hoi AB et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995: 20: 790.
30. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002: 122: 262.
31. Vergis EN, Hayden MK, Chow JW et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 2001: 135: 484.